Abstract
Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
-
Aging
-
Animals
-
Antiparkinson Agents / pharmacology
-
Calcium / metabolism
-
Calcium / pharmacology
-
Calcium Channels, L-Type / deficiency
-
Calcium Channels, L-Type / genetics
-
Calcium Channels, L-Type / metabolism*
-
Dendrites / metabolism
-
Disease Models, Animal*
-
Disease Progression
-
Dopamine / metabolism
-
Electric Conductivity
-
Gene Deletion
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mitochondria / drug effects
-
Models, Neurological*
-
Neurons / cytology*
-
Neurons / drug effects
-
Neurons / metabolism
-
Neurons / pathology*
-
Parkinson Disease / drug therapy
-
Parkinson Disease / metabolism
-
Parkinson Disease / pathology*
-
Parkinson Disease / prevention & control
-
Rotenone / pharmacology
-
Substantia Nigra / cytology
-
Substantia Nigra / metabolism
-
Substantia Nigra / pathology
Substances
-
Antiparkinson Agents
-
Cacna1d protein, mouse
-
Calcium Channels, L-Type
-
Rotenone
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Calcium
-
Dopamine